Bionano Genomics (BNGO) Retained Earnings (2017 - 2026)

Bionano Genomics (BNGO) has 10 years of Retained Earnings data on file, last reported at -$727.9 million in Q1 2026.

• For the quarter ending Q1 2026, Retained Earnings fell 4.53% year-over-year to -$727.9 million; the trailing twelve-month figure through Mar 2026 stood at -$727.9 million (down 4.53% YoY), and the FY2025 full-year result was $17000.0, down 37.04% from the prior year.
• Retained Earnings eased to -$727.9 million in Q1 2026, from $17000.0 in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $1.5 million in Q3 2024 to a low of -$727.9 million in Q1 2026.
• A 5-year average of -$300.7 million and a median of -$310.0 million in 2022 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings jumped 102.05% in 2023 and slumped 23439366.67% in 2025, its largest moves.
• Tracing BNGO's Retained Earnings over 5 years: stood at -$1.1 million in 2022, then jumped by 102.05% to $23000.0 in 2023, then grew by 17.39% to $27000.0 in 2024, then tumbled by 37.04% to $17000.0 in 2025, then plunged by 4281864.71% to -$727.9 million in 2026.
• Business Quant data shows BNGO's Retained Earnings at -$727.9 million in Q1 2026, $17000.0 in Q4 2025, and -$711.7 million in Q3 2025.